Safety and Efficacy of Autologous Myoblast Sheets Treatment for Patients with Severe Heart Failure due to Chronic ischemic Heart Disease. - Safety and Efficacy of Autologous Myoblast Sheets Treatment for Patients with Severe Heart Failure due to Chronic ischemic Heart Disease.

Terumo Corporation0 个研究点目标入组 6 人开始时间: 2012年5月23日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Patients who have signs of skeletal muscle disease. (2) Patients under treatment with thyroid hormone. (3) Patients with infectious disease(HIV,HBV,HCV,HTLV1). (4) Patients in shock due to worsening heart failure. (5) Patients with intercurrent cardiovascular abnormalities that are judged to affect the clinical trial by the investigator or the sub investigators. (6) Patients with irreversible organ failure other than the heart. (7) Patients with a malignant tumor. (8) Patients who are pregnant or possibly pregnant. (9) Patients who cannot receive a blood transfusion. (10) Patients with a history of drug addiction or alcohol addiction within 6 months before obtaining informed consent.(11) Patients with hypersensitivity to antibiotics or animal origin materials such as fetal bovine serum. (12) Patients with severe pulmonary hypertension. (13) Patients with a history of other clinical study within 6 months. (14) Patients who are judged to be inappropriate for the study by the investigator or the sub investigators.

发起方